In short
GAXILOSE, also known as LacTEST, is a diagnostic tool being evaluated in clinical trials for the diagnosis of hypolactasia (lactase deficiency) in adults and elderly patients who present with symptoms of lactose intolerance. This article explores a clinical trial that compares GAXILOSE with the traditional Hydrogen Breath Test (HBT) to determine its effectiveness, impact on patient management, and reproducibility as a diagnostic method. Understanding these clinical evaluations helps patients comprehend how this new diagnostic approach might improve the accuracy and convenience of lactose intolerance testing.
Key points
- GAXILOSE (marketed as LacTEST) is being evaluated in clinical trials as a diagnostic tool for hypolactasia, the underlying cause of lactose intolerance. The study compares GAXILOSE with the standard Hydrogen Breath Test to determine if it provides comparable diagnostic accuracy while assessing its reproducibility and safety profile. Patients take 0.45g of GAXILOSE orally, followed by urine collection over 4-5 hours for xylose measurement, which indicates lactase activity levels. The trial specifically focuses on adults and elderly patients presenting with clinical symptoms of lactose intolerance, with outcomes measured through Visual Analogical Scales and physician questionnaires. If proven effective, GAXILOSE could provide clinicians with a reliable alternative method for diagnosing lactose intolerance.
What is GAXILOSE (LacTEST)?
GAXILOSE, also known as LacTEST, is a diagnostic tool used to identify hypolactasia in adults and elderly patients who show symptoms of lactose intolerance. Hypolactasia is the medical term for lactase deficiency, which is the underlying cause of lactose intolerance. Lactase is an enzyme that helps your body break down lactose, the main sugar found in milk and dairy products.
Purpose of GAXILOSE
GAXILOSE is specifically designed to diagnose hypolactasia in patients who present with clinical symptoms of lactose intolerance. These symptoms typically include bloating, diarrhea, abdominal pain, and gas after consuming dairy products. The test helps doctors confirm whether these symptoms are indeed caused by lactose intolerance or if another condition might be responsible.
How GAXILOSE Works
The GAXILOSE test involves a simple process that can be completed in a few hours:
- You'll be given 0.45 grams of gaxilose to take orally (by mouth).
- After taking gaxilose, your urine will be collected over a period of 5 hours.
- The urine is collected in two parts: first from 0 to 4 hours after taking gaxilose, and then the total urine from 0 to 5 hours.
- The collected urine samples are then analyzed to measure the amount of xylose (a type of sugar) that your body has produced after processing the gaxilose.
The presence and amount of xylose in your urine can indicate whether you have hypolactasia. If your body has normal levels of lactase enzyme, it will properly break down the gaxilose and produce a certain amount of xylose. If you have hypolactasia, less xylose will be detected in your urine.
Comparison with Other Tests
One of the main aims of clinical research on GAXILOSE is to compare its effectiveness to the Hydrogen Breath Test (HBT), which is another commonly used test for diagnosing lactose intolerance. The HBT involves consuming 25 to 50 grams of lactose and then measuring the hydrogen in your breath over several hours.
Research is evaluating whether GAXILOSE is non-inferior to HBT in terms of:
- Impact on diagnostic thinking - how it affects the doctor's ability to diagnose hypolactasia
- Impact on patient management - how it influences the treatment plan for patients
- Reproducibility - whether the test gives consistent results when repeated
These comparisons are being assessed using validated methods such as Visual Analogical Scales (VAS) and physician questionnaires.
Safety Profile
The safety of GAXILOSE is being closely monitored during clinical trials. Researchers are recording any treatment-related adverse events (side effects) that occur during testing. These events are classified using the MedDRA thesaurus, which is a standardized medical terminology used for reporting adverse events. The collected data will help establish the safety profile of GAXILOSE compared to other diagnostic tests for lactose intolerance.
Patient Experience
GAXILOSE testing is designed to be relatively simple for patients. Unlike some other diagnostic procedures, it only requires taking the medication once and collecting urine samples over a 5-hour period. This makes it potentially less burdensome than tests that require multiple samples or longer monitoring periods.
If you're experiencing symptoms that might be related to lactose intolerance, your doctor may consider using GAXILOSE as part of the diagnostic process to determine whether hypolactasia is the cause of your symptoms.